Results
|
|
979141.
|
|
|
|
979142.
|
|
|
|
979143.
|
|
|
|
979144.
|
|
|
|
979145.
|
|
|
|
979146.
|
|
|
|
979147.
|
|
|
|
979148.
|
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†. [electronic resource] by
- Chauffert, B
- Feuvret, L
- Bonnetain, F
- Taillandier, L
- Frappaz, D
- Taillia, H
- Schott, R
- Honnorat, J
- Fabbro, M
- Tennevet, I
- Ghiringhelli, F
- Guillamo, J S
- Durando, X
- Castera, D
- Frenay, M
- Campello, C
- Dalban, C
- Skrzypski, J
- Chinot, O
Producer: 20150831
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 25
Availability: No items available.
|
|
|
979149.
|
|
|
|
979150.
|
|
|
|
979151.
|
|
|
|
979152.
|
|
|
|
979153.
|
|
|
|
979154.
|
|
|
|
979155.
|
|
|
|
979156.
|
|
|
|
979157.
|
|
|
|
979158.
|
|
|
|
979159.
|
|
|
|
979160.
|
|